Glutaminergic Agents for Cocaine Abuse - 5

• Status: Completed
• Trial end date: 1999-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yale University
• Collaborators: National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System
• Treatments: Cocaine; Nimodipine

Criteria

Please contact site for information.